Bruker Corp. (BRKR) to Issue Quarterly Dividend of $0.04 on December 23rd
Bruker Corp. (NASDAQ:BRKR) announced a quarterly dividend on Tuesday, November 15th. Stockholders of record on Monday, December 5th will be paid a dividend of 0.04 per share on Friday, December 23rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.70%. The ex-dividend date is Thursday, December 1st.
Shares of Bruker Corp. (NASDAQ:BRKR) opened at 22.96 on Friday. The company has a market capitalization of $3.68 billion, a price-to-earnings ratio of 25.94 and a beta of 1.04. Bruker Corp. has a 52 week low of $19.58 and a 52 week high of $29.85. The stock has a 50 day moving average of $21.79 and a 200-day moving average of $23.25.
Bruker Corp. (NASDAQ:BRKR) last issued its earnings results on Wednesday, November 2nd. The company reported $0.32 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.20 by $0.12. Bruker Corp. had a net margin of 9.02% and a return on equity of 26.05%. The company had revenue of $393.90 million for the quarter, compared to analysts’ expectations of $394.14 million. During the same period in the prior year, the business earned $0.19 EPS. The firm’s quarterly revenue was down .6% on a year-over-year basis. On average, analysts anticipate that Bruker Corp. will post $1.10 EPS for the current year.
Several research analysts have issued reports on BRKR shares. Janney Montgomery Scott upgraded shares of Bruker Corp. from a “neutral” rating to a “buy” rating and set a $28.00 target price on the stock in a report on Wednesday, August 3rd. Leerink Swann started coverage on shares of Bruker Corp. in a report on Thursday, November 10th. They set a “market perform” rating and a $21.00 target price on the stock. Wells Fargo & Co. cut shares of Bruker Corp. from an “outperform” rating to a “market perform” rating in a report on Wednesday, August 3rd. Mizuho dropped their target price on shares of Bruker Corp. from $28.00 to $23.00 and set a “neutral” rating on the stock in a report on Wednesday, August 3rd. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $28.00 price target on shares of Bruker Corp. in a research report on Thursday, November 3rd. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average price target of $25.73.
A number of institutional investors have recently bought and sold shares of the company. The Manufacturers Life Insurance Company acquired a new position in Bruker Corp. during the third quarter worth about $106,000. SG Americas Securities LLC raised its position in Bruker Corp. by 21.2% in the third quarter. SG Americas Securities LLC now owns 7,182 shares of the company’s stock worth $163,000 after buying an additional 1,255 shares in the last quarter. Pacer Advisors Inc. acquired a new position in Bruker Corp. during the second quarter worth about $189,000. AMP Capital Investors Ltd acquired a new position in Bruker Corp. during the third quarter worth about $232,000. Finally, Seven Eight Capital LLC raised its position in Bruker Corp. by 2.6% in the second quarter. Seven Eight Capital LLC now owns 11,700 shares of the company’s stock worth $266,000 after buying an additional 300 shares in the last quarter. 68.90% of the stock is owned by institutional investors.
About Bruker Corp.
Bruker Corporation is a designer and manufacturer of scientific instruments, and analytical and diagnostic solutions. The Company’s operating segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Receive News & Stock Ratings for Bruker Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corp. and related stocks with our FREE daily email newsletter.